NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View Denis AngoulvantPierre SabouretMichael P. Savage Current Opinion Open access 06 March 2021 Pages: 483 - 486
Angiotensin-Converting Enzyme Inhibitors and Contrast-Associated Acute Kidney Injury After Coronary Angiography and Intervention Melissa WasilewskiSumon RoyIon S. Jovin Review Article 28 December 2020 Pages: 487 - 497
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes Subuhi KaulManasvi GuptaRaktim K. Ghosh Review Article 28 December 2020 Pages: 499 - 512
Use of Ranolazine for the Treatment of Coronary Microvascular Dysfunction Randall P. SharpEdna PatatanianRiaz Sirajuddin Review Article 13 January 2021 Pages: 513 - 521
Antithrombotic Therapy in Peripheral Artery Disease: Stepping in the Right Direction Kristin R. HandGenevieve M. Hale Review Article 21 February 2021 Pages: 523 - 534
Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis Camille VongMartin BoucherLutz O. Harnisch Original Research Article Open access 26 March 2021 Pages: 535 - 543
Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing ≥ 120 Kilograms versus 60–120 Kilograms Eryne E. WiethornCarolyn Magee BellBarbara S. Wiggins Original Research Article 30 March 2021 Pages: 545 - 551
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II) Larry R. Jackson IIPeter Schraderthe Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) II Investigators and Patients Original Research Article 31 March 2021 Pages: 553 - 561
Use of Flecainide in Stable Coronary Artery Disease: An Analysis of Its Safety in Both Nonobstructive and Obstructive Coronary Artery Disease Hasan AshrafNway Ko KoDan Sorajja Original Research Article 18 June 2021 Pages: 563 - 572
Joint Latent Class Analysis of Oral Anticoagulation Use and Risk of Stroke or Systemic Thromboembolism in Patients with Atrial Fibrillation Nemin ChenNico GabrielInmaculada Hernandez Original Research Article 12 April 2021 Pages: 573 - 580
Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries Inmaculada HernandezMina TadrousKatie J. Suda Research Letter 26 March 2021 Pages: 581 - 583